Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #2160894

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)	4 441 EUR	—	4 441 EUR	—	5 472 EUR	5 472 EUR	—
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories	118,000 EUR	—	—	—	68,000 EUR	—	—
Other adjustments for non-cash items	289,000 EUR	—	—	—	770,000 EUR	—	—
Cash flows from (used in) operations	354,000 EUR	—	—	—	2 171 EUR	—	—
Interest paid, classified as operating activities	169,000 EUR	—	—	—	76,000 EUR	—	—
Cash flows from (used in) operating activities	615,000 EUR	—	—	—	2 370 EUR	—	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	213,000 EUR	—	—	—	780,000 EUR	—	—
Purchase of intangible assets, classified as investing activities	2 199 EUR	—	—	—	2 249 EUR	—	—
Cash flows from (used in) investing activities	2 412 EUR	—	—	—	3 029 EUR	—	—
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares	4 310 EUR	—	—	—	9 012 EUR	—	—
Repayments of borrowings, classified as financing activities	1 921 EUR	—	—	—	912,000 EUR	—	—
Payments of lease liabilities, classified as financing activities	462,000 EUR	—	—	—	415,000 EUR	—	—
Cash flows from (used in) financing activities	1 609 EUR	—	—	—	7 003 EUR	—	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	1 419 EUR	—	—	—	1 605 EUR	—	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	13,000 EUR	—	—	—	115,000 EUR	—	—
Cash and cash equivalents	—	7 118 EUR	—	8 524 EUR	—	—	6 804 EUR